Nina Capital

Activity from announced rounds

Activity in this selectionOct 24, 2026 · Biotech · Jan 1, 2026
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$15M
1 disclosed · full round size, not this investor’s share

By stage

Seed1
Series A1

By primary sector

Healthtech2

By country

Switzerland1
United States1

Rounds

2 in this selection
Rivia

Builds a data engine for clinical trial intelligence to unify fragmented data and enable AI-driven insights

$15MSeries A
Role not disclosed
Navidence

Provides AI-native platform with standardized computable definitions of diseases and outcomes for real-world evidence research

Role not disclosed